Skip to main content
Top
Published in: Annals of Surgical Oncology 3/2018

01-12-2018 | ASO Author Reflections

Sarcopenia After Resection of Early Non-small Cell Lung Cancer: Is Postoperative Skeletal Muscle Loss a Risk Factor for Poor Outcomes?

Authors: Shinkichi Takamori, MD, Gouji Toyokawa, PhD

Published in: Annals of Surgical Oncology | Special Issue 3/2018

Login to get access

Excerpt

The clinical concept of skeletal muscle loss was proposed by Irwin Rosenberg for the first time in 1989.1 Skeletal muscle loss is caused by several mechanisms, including physical inactivity, inadequate nutrition, and cachexia. In patients with cancer, skeletal muscle loss has drawn a lot of attention since Prado et al.2 reported that pretreatment skeletal muscle decrease was significantly associated with poor outcomes in patients with solid tumors. However, in most previous studies, skeletal muscle amount was only analyzed at one time point during the pretreatment period, and few studies focused on the clinical impact of changes in skeletal muscle during medical interventions. Therefore, this study investigated whether postoperative changes in skeletal muscle after curative lung resection has a clinical role in patients with early non-small cell lung cancer (NSCLC). Additionally, we investigated which clinicopathological factors were significantly associated with the risk of postoperative skeletal muscle loss. …
Literature
1.
2.
go back to reference Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9(7):629–35.CrossRefPubMed Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9(7):629–35.CrossRefPubMed
3.
go back to reference Takamori S, Toyokawa G, Okamoto T, et al. Clinical impact and risk factors for skeletal muscle loss after complete resection of early non-small cell lung cancer. Ann Surg Oncol. 2018;25(5):1229–36.CrossRefPubMed Takamori S, Toyokawa G, Okamoto T, et al. Clinical impact and risk factors for skeletal muscle loss after complete resection of early non-small cell lung cancer. Ann Surg Oncol. 2018;25(5):1229–36.CrossRefPubMed
4.
go back to reference Kudou K, Komatsu T, Nogami J, et al. The requirement of Mettl3-promoted MyoD mRNA maintenance in proliferative myoblasts for skeletal muscle differentiation. Open Biol. 2017;7(9): pii: 170119. Kudou K, Komatsu T, Nogami J, et al. The requirement of Mettl3-promoted MyoD mRNA maintenance in proliferative myoblasts for skeletal muscle differentiation. Open Biol. 2017;7(9): pii: 170119.
5.
go back to reference Meyerhardt JA, Heseltine D, Niedzwiecki D, et al. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol. 2006;24(22):3535–41.CrossRefPubMed Meyerhardt JA, Heseltine D, Niedzwiecki D, et al. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol. 2006;24(22):3535–41.CrossRefPubMed
Metadata
Title
Sarcopenia After Resection of Early Non-small Cell Lung Cancer: Is Postoperative Skeletal Muscle Loss a Risk Factor for Poor Outcomes?
Authors
Shinkichi Takamori, MD
Gouji Toyokawa, PhD
Publication date
01-12-2018
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2018
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-018-6784-z

Other articles of this Special Issue 3/2018

Annals of Surgical Oncology 3/2018 Go to the issue